Clinical analysis of outcomes of microwave therapy in treating cervical HPV sub-clinical infections
GUO Ying1,YE Qingjian2,LIN Mengyuan2,YANG Yuebo2,and LI Xiaomao2
1.Department of Gynecology, Guangzhou iBorn Women’s & Children’s Hospital, Guangzhou 510630,China; 2.Department of Gynecology, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630,China
Abstract：Objective To investigate the effectiveness of microwave therapy in clearing HPV infections.Methods One hundred and sixty-five cases of cervical HPV infections were enrolled in this study, who were assigned into treatment group( microwave therapy group; 47 cases), and control group(118 cases). The therapeutic effect on HPV infections was compared between the two groups.Results The median HPV clearance time of the microwave group was 194 days(ranging from 72 to 532 days), while that of the control group was 284 days (ranging from 119 to 777 days). HPV clearance rates of the microwave group and control group were 93.6%(44 cases ) and 77.1%(91 cases)respectively, so the difference was statistically significant (P<0.05).Conclusions The microwave treatment is a safe and reliable approach to cervical HPV sub-clinical infections, which can not only increase the clearance rate, but also reduce the clearance time.
Guan P,Howell-Jones R,Li N,et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer[J]. Int J Cancer,2012,131(10): 2349-2359.
[2]
Centers for Disease Control and Prevention, Sexually transmitted diseases treatment guidelines[J]. MMWR Recomm Rep, 2015,64(RR-03): 1-137.
[3]
Kollipara R,Ekhlassi E, Downing C,et al.Advancements in Pharmacotherapy for Noncancerous Manifestations of HPV[J]. J Clin Med, 2015,4(5): 832-846.
ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 61, April 2005. Human papillomavirus[J]. Obstet Gynecol, 2005,105(4): 905-918.
[6]
Lin C T,Qiu J T, Wang C J,et al. Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia[J]. Taiwan J Obstet Gynecol, 2012,51(4): 533-538.
2018, Vol. 29 
